Evommune, Inc.
EVMN
$20.49
$0.301.49%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 336.78% | 107.11% | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -25.73% | 119.61% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 297.33% | 107.44% | -- | -- | -- |
|
|
|||||
| Total Current Assets | 297.33% | 107.44% | -- | -- | -- |
| Net Property, Plant & Equipment | 573.47% | 36.99% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 450.93% | 463.57% | -- | -- | -- |
| Total Assets | 475.65% | 195.77% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | -46.59% | -6.15% | -- | -- | -- |
| Total Accrued Expenses | 2.31% | 41.88% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 94.57% | 20.94% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -93.79% | -99.86% | -- | -- | -- |
| Total Other Current Liabilities | -93.79% | -99.86% | -- | -- | -- |
| Total Current Liabilities | -51.89% | -36.00% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -51.89% | -36.00% | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1,585.22% | 174.95% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -20.37% | -32.04% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 6,310.38% | 5,245.21% | -- | -- | -- |
| Retained Earnings | -45.56% | -45.24% | -- | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 292.47% | 242.52% | -- | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 292.47% | 242.52% | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 808.09% | 332.42% | -- | -- | -- |
|
|
|||||